Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.2.0.727
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Revenue:        
Product revenues $ 20,000 $ 25,000 $ 27,000 $ 25,000
License revenues 0 0 0 0
TOTAL REVENUE 20,000 25,000 27,000 25,000
Cost of Product Revenue 0 17,000 0 17,000
Gross profit 20,000 8,000 27,000 8,000
Operating Expenses:        
Research and development 0 0 250,000 0
Selling, general and administrative 1,451,000 112,000 3,019,000 213,000
Total operating expenses 1,451,000 112,000 3,269,000 213,000
Loss from Operations (1,431,000) (104,000) (3,242,000) (205,000)
Other income (expense)        
Change in value of warrant and derivative liabilities 29,140,000 11,000 17,874,000 (61,000)
Interest expense (849,000) (168,000) (8,288,000) (365,000)
Total Other Income (Expense) 28,291,000 (157,000) 9,586,000 (426,000)
Income/(loss) before minority interest and provision for income taxes 26,860,000 (261,000) 6,344,000 (631,000)
Plus: net loss attributable to the noncontrolling interest 0 1,000 0 (2,000)
Income/(loss) before provision for income taxes 26,860,000 (262,000) 6,344,000 (633,000)
Provision for income taxes 0 0 0 0
Net income/(loss) $ 26,860,000 $ (262,000) $ 6,344,000 $ (633,000)
Weighted Average Common Shares Outstanding - Basic 599,095,280 573,051,524 597,270,051 573,051,524
Weighted Average Common Shares Outstanding - Diluted 1,226,809,602 573,051,524 1,224,992,332 573,051,524
Income (loss) per share - Basic $ 0.05 $ 0.00 $ 0.01 $ 0.00
Income (loss) per share - Diluted $ 0.02 $ 0.00 $ 0.01 $ 0.00